#AACR25: Revolution’s KRAS drug shows potential in early cut of lung cancer data

CHICAGO — An experimental KRAS G12D drug from Revolution Medicines made waves last year as a potential treatment for pancreatic cancer. On Sunday, new results from an early data readout showed it works on lung ...